| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11095-016-2080-4 |
| P698 | PubMed publication ID | 27995523 |
| P50 | author | Angelina Angelova | Q50905335 |
| P2093 | author name string | Valérie Nicolas | |
| Luis P B Guerzoni | |||
| P2860 | cites work | Pathways towards and away from Alzheimer's disease | Q24596270 |
| Neurotrophin-regulated signalling pathways | Q24678332 | ||
| The structures of the neurotrophin 4 homodimer and the brain-derived neurotrophic factor/neurotrophin 4 heterodimer reveal a common Trk-binding site | Q27620951 | ||
| Spreading of pathology in neurodegenerative diseases: a focus on human studies | Q28082279 | ||
| Phytochemicals that regulate neurodegenerative disease by targeting neurotrophins: a comprehensive review | Q28263471 | ||
| Neurotrophins and their receptors: a convergence point for many signalling pathways | Q29616108 | ||
| Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo | Q29619108 | ||
| Statistical analysis of high-resolution light microscope images reveals effects of cytoskeleton-disrupting drugs on the membrane organization of the nicotinic acetylcholine receptor | Q33598896 | ||
| Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease | Q33726762 | ||
| Activation of Trk neurotrophin receptors in the absence of neurotrophins | Q33937877 | ||
| The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. | Q33955271 | ||
| Brain-derived neurotrophic factor in neurodegenerative diseases | Q34017880 | ||
| Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes | Q34028178 | ||
| Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease | Q34065279 | ||
| BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog | Q34110817 | ||
| Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents | Q34111160 | ||
| Biochemical and biophysical investigation of the brain-derived neurotrophic factor mimetic 7,8-dihydroxyflavone in the binding and activation of the TrkB receptor | Q34283434 | ||
| BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases | Q34344683 | ||
| Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease | Q34366768 | ||
| Cubic phase nanoparticles (Cubosome): principles for controlling size, structure, and stability | Q34400688 | ||
| Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway | Q34652379 | ||
| In-depth quantitative proteomic analysis of de novo protein synthesis induced by brain-derived neurotrophic factor | Q34669612 | ||
| Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. | Q34771008 | ||
| Synaptic therapy in Alzheimer's disease: a CREB-centric approach | Q35064948 | ||
| Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain | Q35285811 | ||
| Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. | Q35586627 | ||
| Brain-derived neurotrophic factor and neuropsychiatric disorders | Q35847085 | ||
| Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration | Q36302085 | ||
| The expanding role of BDNF: a therapeutic target for Alzheimer's disease? | Q36325596 | ||
| Novel antioxidants protect mitochondria from the effects of oligomeric amyloid beta and contribute to the maintenance of epigenome function | Q36818189 | ||
| Cubic membranes: a structure-based design for DNA uptake | Q37024343 | ||
| Shaping neurons: Long and short range effects of mature and proBDNF signalling upon neuronal structure | Q37213551 | ||
| Nanoparticles for direct nose-to-brain delivery of drugs. | Q37531152 | ||
| Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. | Q37613149 | ||
| The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity | Q37699054 | ||
| Transactivation of Trk receptors in spinal motor neurons | Q37770468 | ||
| CREB: a multifaceted regulator of neuronal plasticity and protection | Q37806285 | ||
| Neurotherapeutic applications of nanoparticles in Alzheimer's disease | Q37816572 | ||
| Repairing the parkinsonian brain with neurotrophic factors | Q37818693 | ||
| Potential therapeutic uses of BDNF in neurological and psychiatric disorders | Q37848053 | ||
| Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery. | Q37926636 | ||
| Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. | Q37943575 | ||
| Nanotechnological advances for the delivery of CNS therapeutics | Q37958426 | ||
| Brain Derived Neurotrophic Factor: a novel neurotrophin involved in psychiatric and neurological disorders | Q37979058 | ||
| Lipid-based nanocarriers for CNS-targeted drug delivery | Q37979219 | ||
| Neuroprotective potential of phytochemicals | Q38051297 | ||
| STED microscopy of living cells--new frontiers in membrane and neurobiology. | Q38090722 | ||
| BDNF-induced local protein synthesis and synaptic plasticity | Q38100505 | ||
| Neurotrophin delivery using nanotechnology | Q38124641 | ||
| From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF) | Q38168376 | ||
| Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. | Q38170374 | ||
| 7,8-Dihydroxyflavone as a pro-neurotrophic treatment for neurodevelopmental disorders. | Q38556634 | ||
| The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier? | Q38580477 | ||
| Neuronal Uptake and Neuroprotective Properties of Curcumin-Loaded Nanoparticles on SK-N-SH Cell Line: Role of Poly(lactide-co-glycolide) Polymeric Matrix Composition | Q38815786 | ||
| CREB expression mediates amyloid β-induced basal BDNF downregulation | Q38869520 | ||
| Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease. | Q38985632 | ||
| Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment | Q39079971 | ||
| Eicosapentaenoic acid (EPA) increases cell viability and expression of neurotrophin receptors in retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cells | Q39999348 | ||
| Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels | Q40382502 | ||
| Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis | Q40386753 | ||
| DNA/Fusogenic Lipid Nanocarrier Assembly: Millisecond Structural Dynamics | Q40632460 | ||
| Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells | Q40862772 | ||
| Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect | Q40867529 | ||
| BDNF stimulation of protein synthesis in cortical neurons requires the MAP kinase-interacting kinase MNK1. | Q41546726 | ||
| Identification of large channels in cationic PEGylated cubosome nanoparticles by synchrotron radiation SAXS and Cryo-TEM imaging | Q41605836 | ||
| Curcumin containing monoolein aqueous dispersions: a preformulative study | Q41610122 | ||
| Protein entrapment in PEGylated lipid nanoparticles | Q41610773 | ||
| Earliest stage of the tetrahedral nanochannel formation in cubosome particles from unilamellar nanovesicles | Q41612181 | ||
| Delivery of brain-derived neurotrophic factor via nose-to-brain pathway | Q42380871 | ||
| Enhanced CREB phosphorylation in immature dentate gyrus granule cells precedes neurotrophin expression and indicates a specific role of CREB in granule cell differentiation | Q42746748 | ||
| Withdrawal of BDNF from hippocampal cultures leads to changes in genes involved in synaptic function | Q43148661 | ||
| Natural extracts as possible protective agents of brain aging | Q44188934 | ||
| Antioxidant vitamin intake and risk of Alzheimer disease | Q44311362 | ||
| Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. | Q44626624 | ||
| Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons | Q45235102 | ||
| Phenolics as potential antioxidant therapeutic agents: mechanism and actions | Q46205891 | ||
| Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway | Q47756984 | ||
| Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF. | Q48405142 | ||
| Why neurons die: cell death in the nervous system. | Q48412746 | ||
| Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress | Q48457738 | ||
| CREB: a major mediator of neuronal neurotrophin responses | Q48589882 | ||
| Self-amplified BDNF transcription is a regulatory system for synaptic maturation in cultured cortical neurons. | Q50553700 | ||
| A novel small Odorranalectin-bearing cubosomes: preparation, brain delivery and pharmacodynamic study on amyloid-β₂₅₋₃₅-treated rats following intranasal administration. | Q51848225 | ||
| Brain-derived neurotrophic factor stimulates AP-1 and cyclic AMP-responsive element dependent transcriptional activity in central nervous system neurons. | Q54178637 | ||
| Validation of an Ultraviolet–visible (UV–Vis) technique for the quantitative determination of curcumin in poly(l-lactic acid) nanoparticles | Q57646575 | ||
| Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells | Q63991177 | ||
| Distribution of nerve growth factor following direct delivery to brain interstitium | Q72033017 | ||
| Protein driven patterning of self-assembled cubosomic nanostructures: long oriented nanoridges | Q79935308 | ||
| Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design | Q84595894 | ||
| Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal | Q84857902 | ||
| P433 | issue | 2 | |
| P921 | main subject | curcumin | Q312266 |
| P304 | page(s) | 492-505 | |
| P577 | publication date | 2016-12-19 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival | |
| P478 | volume | 34 |
| Q57210218 | AAV-Syn-BDNF-EGFP Virus Construct Exerts Neuroprotective Action on the Hippocampal Neural Network during Hypoxia In Vitro |
| Q60949564 | Amphiphilic Nanocarrier Systems for Curcumin Delivery in Neurodegenerative Disorders |
| Q92826501 | Cubic Liquid Crystalline Nanostructures Involving Catalase and Curcumin: BioSAXS Study and Catalase Peroxidatic Function after Cubosomal Nanoparticle Treatment of Differentiated SH-SY5Y Cells |
| Q64057321 | Curcumin Ameliorates the Impaired Insulin Signaling Involved in the Pathogenesis of Alzheimer's Disease in Rats |
| Q92629828 | Curcumin as a Therapeutic Option in Retinal Diseases |
| Q38650579 | Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair |
| Q53697170 | Effect of Chemical Binding of Doxorubicin Hydrochloride to Gold Nanoparticles, Versus Electrostatic Adsorption, on the In Vitro Drug Release and Cytotoxicity to Breast Cancer Cells. |
| Q48257489 | General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes. |
| Q55342440 | Harnessing migraines for neural regeneration. |
| Q55252451 | Impact of nanoparticles on neuron biology: current research trends. |
| Q90335180 | Liquid Crystalline Nanostructures as PEGylated Reservoirs of Omega-3 Polyunsaturated Fatty Acids: Structural Insights toward Delivery Formulations against Neurodegenerative Disorders |
| Q58702703 | Molecular mechanism of panaxydol on promoting axonal growth in PC12 cells |
| Q64911591 | Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy. |
| Q50905291 | Nanoscale clustering of the neurotrophin receptor TrkB revealed by super-resolution STED microscopy. |
| Q92979830 | Polyhexamethylene Biguanide and Nadifloxacin Self-Assembled Nanoparticles: Antimicrobial Effects against Intracellular Methicillin-Resistant Staphylococcus aureus |
| Q64259913 | The Neuroprotective Effect of Extracts in Mouse Hippocampus after Pilocarpine-Induced Status Epilepticus |
| Q92920850 | The Role of Altered BDNF/TrkB Signaling in Amyotrophic Lateral Sclerosis |
Search more.